Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

Title:	Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Authors:	King, Brett^Aff1; Soung, Jennifer^Aff2; Tziotzios, Christos^Aff3; Rudnicka, Lidia^Aff4; Joly, Pascal^Aff5; Gooderham, Melinda^Aff6; Sinclair, Rodney^Aff7; Mesinkovska, Natasha A.^Aff8; Paul, Carle^Aff9; Gong, Yankun^Aff10; Anway, Susan D.^Aff11; Tran, Helen^Aff10; Wolk, Robert^Aff11; Zwillich, Samuel H.^Aff11; Lejeune, Alexandre^{Aff12, IDs40257025009762_cor1}
Source:	American Journal of Clinical Dermatology. 26(6):1065-1065
Database:	Springer Nature Journals